Nano Cap New Millennium Growth Fund L P Makes New Investment in Simulations Plus, Inc. $SLP

Nano Cap New Millennium Growth Fund L P acquired a new stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 97,000 shares of the technology company’s stock, valued at approximately $1,768,000. Simulations Plus makes up about 1.5% of Nano Cap New Millennium Growth Fund L P’s portfolio, making the stock its 14th biggest position. Nano Cap New Millennium Growth Fund L P owned approximately 0.48% of Simulations Plus at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Tudor Investment Corp ET AL purchased a new stake in Simulations Plus in the third quarter worth $1,810,000. Royce & Associates LP lifted its position in Simulations Plus by 31.6% during the third quarter. Royce & Associates LP now owns 348,758 shares of the technology company’s stock valued at $5,256,000 after buying an additional 83,758 shares during the period. Nicholas Company Inc. boosted its holdings in shares of Simulations Plus by 42.9% during the 4th quarter. Nicholas Company Inc. now owns 262,712 shares of the technology company’s stock valued at $4,789,000 after buying an additional 78,854 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Simulations Plus by 154.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 167,646 shares of the technology company’s stock valued at $2,526,000 after buying an additional 101,822 shares in the last quarter. Finally, Herald Investment Management Ltd purchased a new stake in shares of Simulations Plus in the 3rd quarter worth about $3,016,000. Institutional investors own 78.08% of the company’s stock.

Analyst Upgrades and Downgrades

SLP has been the subject of a number of recent research reports. Wall Street Zen raised shares of Simulations Plus from a “hold” rating to a “buy” rating in a research report on Saturday, May 16th. Zacks Research lowered shares of Simulations Plus from a “strong-buy” rating to a “hold” rating in a report on Monday, February 2nd. Finally, TD Cowen dropped their price target on Simulations Plus from $19.00 to $16.00 and set a “hold” rating on the stock in a research report on Friday, April 10th. Three analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $24.40.

Simulations Plus Stock Performance

Shares of NASDAQ SLP opened at $15.11 on Friday. The firm’s 50 day moving average price is $13.40 and its 200-day moving average price is $15.66. Simulations Plus, Inc. has a 52-week low of $11.09 and a 52-week high of $34.01. The company has a market cap of $305.22 million, a PE ratio of -4.83 and a beta of 1.28.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Thursday, April 9th. The technology company reported $0.35 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.08. The company had revenue of $24.29 million during the quarter, compared to analyst estimates of $21.66 million. Simulations Plus had a negative net margin of 77.96% and a positive return on equity of 16.21%. On average, analysts forecast that Simulations Plus, Inc. will post 0.85 earnings per share for the current fiscal year.

Simulations Plus Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.